Entos Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Edmonton, Alberta--(Newsfile Corp. - April 9, 2024) - Entos Pharmaceuticals, (Entos), a genetic medicines company pioneering the development of life-changing medicines to patients with its Fusogenix PLV nucleic acid delivery technology, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre.
- Edmonton, Alberta--(Newsfile Corp. - April 9, 2024) - Entos Pharmaceuticals, (Entos), a genetic medicines company pioneering the development of life-changing medicines to patients with its Fusogenix PLV nucleic acid delivery technology, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre.